Published in Eur J Clin Invest on June 01, 2002
Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep (2007) 4.14
Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes Rev (2009) 1.83
TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.73
Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer (2010) 1.35
Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr (2011) 1.26
Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse. Endocrinology (2010) 1.24
Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of "metabolic memory". Exp Diabetes Res (2011) 1.21
Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism (2010) 1.16
Effect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice. Basic Res Cardiol (2010) 1.08
Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling. Cell Calcium (2010) 1.07
The role of chronic inflammation in obesity-associated cancers. ISRN Oncol (2013) 1.04
Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3). Proc Natl Acad Sci U S A (2004) 1.00
Eicosanoids and renal damage in cardiometabolic syndrome. Expert Opin Drug Metab Toxicol (2008) 0.99
Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes. Diabetes (2012) 0.98
Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction. J Biol Chem (2014) 0.96
The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes. Cell Calcium (2011) 0.95
Increased serum CXCL1 and CXCL5 are linked to obesity, hyperglycemia, and impaired islet function. J Endocrinol (2014) 0.93
Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo. Cardiovasc Diabetol (2013) 0.92
Diabetes and Hepatitis C: A Two-Way Association. Front Endocrinol (Lausanne) (2015) 0.89
The Anti-Inflammatory Actions of Exercise Training. Am J Lifestyle Med (2007) 0.89
Habitual Sleep Duration and Risk of Childhood Obesity: Systematic Review and Dose-response Meta-analysis of Prospective Cohort Studies. Sci Rep (2015) 0.88
Deletion of GαZ protein protects against diet-induced glucose intolerance via expansion of β-cell mass. J Biol Chem (2012) 0.87
A novel fluorescence imaging approach for comparative measurements of pancreatic islet function in vitro. Islets (2011) 0.87
Inulin increases short-term markers for colonic fermentation similarly in healthy and hyperinsulinaemic humans. Eur J Clin Nutr (2011) 0.85
Comparison of Lactate Threshold, Glucose, and Insulin Levels Between OLETF and LETO Rats After All-Out Exercise. J Sports Sci Med (2009) 0.85
Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus. Int J Endocrinol (2012) 0.85
Nutrigenomics, beta-cell function and type 2 diabetes. Curr Genomics (2007) 0.84
Metabolic syndrome. Pediatr Rev (2012) 0.84
The role of obesity in gastrointestinal cancer: evidence and opinion. Therap Adv Gastroenterol (2014) 0.82
Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats. Mol Med (2008) 0.81
Lipid Profiles and Serum Visfatin Concentrations in Patients with Type II Diabetes in Comparison with Healthy Controls. Int J Prev Med (2012) 0.81
Elevated plasma SPARC levels are associated with insulin resistance, dyslipidemia, and inflammation in gestational diabetes mellitus. PLoS One (2013) 0.81
Severe insulin resistance in a treatment-naive chronic hepatitis C patient. Gastroenterol Hepatol (N Y) (2008) 0.80
Fetal programming and early identification of newborns at high risk of free radical-mediated diseases. World J Clin Pediatr (2016) 0.78
Expression of toll-like receptor 4 in maternal monocytes of patients with gestational diabetes mellitus. Exp Ther Med (2013) 0.78
A high cholesterol diet elevates hippocampal cytokine expression in an age and estrogen-dependent manner in female rats. J Neuroimmunol (2010) 0.78
Association of hepatitis C virus with insulin resistance: evidences from animal studies and clinical studies. Hepat Mon (2012) 0.77
Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes. J Diabetes Res (2016) 0.77
Identification of the dichotomous role of age-related LCK in calorie restriction revealed by integrative analysis of cDNA microarray and interactome. Age (Dordr) (2012) 0.77
Modulation of immune cells and Th1/Th2 cytokines in insulin-treated type 2 diabetes mellitus. Afr Health Sci (2016) 0.77
A comparative study on hypoglycemic properties, lipid profile and bioactive components of hydro-alcoholic extracts of cooked and raw Brassica napus. J Nephropharmacol (2015) 0.75
Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus. Mol Med Rep (2016) 0.75
Association between Sleep Duration and Measurable Cardiometabolic Risk Factors in Healthy Korean Women: The Fourth and Fifth Korean National Health and Nutrition Examination Surveys (KNHANES IV and V). Int J Endocrinol (2016) 0.75
Effects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in Rats. Med Arch (2017) 0.75
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol (1993) 3.00
Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes (1992) 2.92
Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol (1993) 2.73
A metabolite-regulated potassium channel in rat pancreatic B cells. Proc Natl Acad Sci U S A (1986) 2.27
Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A (1993) 2.06
Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes (1992) 2.04
Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic beta-cells. A possible role in protein translation and mitogenic signaling. J Biol Chem (1998) 1.85
Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest (1992) 1.82
Preliminary characterization of calcium binding in islet-cell plasma membranes. Diabetologia (1980) 1.75
Intracellular Ca2+ mobilization by arachidonic acid. Comparison with myo-inositol 1,4,5-trisphosphate in isolated pancreatic islets. J Biol Chem (1986) 1.70
Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. J Biol Chem (1991) 1.59
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes (1993) 1.59
Effects of sulfonamides on a metabolite-regulated ATPi-sensitive K+ channel in rat pancreatic B-cells. Am J Physiol (1989) 1.51
A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. Methods Enzymol (1983) 1.48
Metabolic regulation by leucine of translation initiation through the mTOR-signaling pathway by pancreatic beta-cells. Diabetes (2001) 1.42
Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med (1995) 1.40
Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am J Physiol Endocrinol Metab (2001) 1.40
IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry (1993) 1.36
Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem J (1992) 1.34
Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol (1993) 1.31
Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem Biophys Res Commun (1993) 1.29
Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion. J Biol Chem (1999) 1.28
Glucose-induced accumulation of inositol trisphosphates in isolated pancreatic islets. Predominance of the 1,3,4-isomer. Biochem J (1986) 1.25
Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes (1987) 1.23
Hyperinsulinism in mice with heterozygous loss of K(ATP) channels. Diabetologia (2006) 1.22
Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci U S A (1993) 1.16
Insulin mediates glucose-stimulated phosphorylation of PHAS-I by pancreatic beta cells. An insulin-receptor mechanism for autoregulation of protein synthesis by translation. J Biol Chem (1998) 1.15
The digitonin-permeabilized pancreatic islet model. Effect of myo-inositol 1,4,5-trisphosphate on Ca2+ mobilization. Biochem J (1985) 1.13
Alloxan uptake by isolated rat islets of Langerhans. Endocrinology (1978) 1.13
Standardization fo a digestion-filtration method for isolation of pancreatic islets. Diabetes (1976) 1.11
Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology (1995) 1.07
Effect of alloxan on insulin secretion in isolated rat islets perifused in vitro. Diabetes (1974) 1.06
Secretagogue-induced oscillations of cytoplasmic Ca2+ in single beta and alpha-cells obtained from pancreatic islets by fluorescence-activated cell sorting. Biochem Biophys Res Commun (1990) 1.06
Correlation of Ca2+-and calmodulin-dependent protein kinase activity with secretion of insulin from islets of Langerhans. Biochem J (1983) 1.04
Comparison of the properties of active Ca2+ transport by the islet-cell endoplasmic reticulum and plasma membrane. Biochim Biophys Acta (1983) 1.03
Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Methods Enzymol (1996) 1.02
Secretagogue-induced diacylglycerol accumulation in isolated pancreatic islets. Mass spectrometric characterization of the fatty acyl content indicates multiple mechanisms of generation. Biochemistry (1989) 1.02
Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest (1990) 1.02
Glucose 6-phosphate regulates Ca2+ steady state in endoplasmic reticulum of islets. A possible link in glucose-induced insulin secretion. J Biol Chem (1986) 1.00
Calmodulin-activated protein kinase activity in rat pancreatic islet cell membranes. Arch Biochem Biophys (1982) 0.99
Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. Neurosci Lett (1993) 0.98
Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol (1996) 0.98
Protein phosphorylation in permeabilized pancreatic islet cells. Biochem J (1985) 0.98
Diacylglycerol synthesis de novo from glucose by pancreatic islets isolated from rats and humans. J Clin Invest (1990) 0.97
Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity (1993) 0.97
GTP mobilization of Ca2+ from the endoplasmic reticulum of islets. Comparison with myo-inositol 1,4,5-trisphosphate. Biochem J (1987) 0.96
Alloxan inhibition of a Ca2+- and calmodulin-dependent protein kinase activity in pancreatic islets. J Biol Chem (1983) 0.96
Arachidonic acid metabolism in isolated pancreatic islets. II. The effects of glucose and of inhibitors of arachidonate metabolism on insulin secretion and metabolite synthesis. Biochim Biophys Acta (1984) 0.96
Arachidonic acid metabolism in isolated pancreatic islets. I. Identification and quantitation of lipoxygenase and cyclooxygenase products. Biochim Biophys Acta (1984) 0.96
Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Am J Physiol (1996) 0.96
Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem J (1994) 0.96
Glucose-induced insulin secretion from purified beta-cells. A role for modulation of Ca2+ influx by cAMP- and protein kinase C-dependent signal transduction pathways. J Biol Chem (1993) 0.96
Active calcium uptake by islet-cell endoplasmic reticulum. J Biol Chem (1982) 0.95
Activation of an islet cell plasma membrane (Ca2+ + Mg2+)-ATPase by calmodulin and Ca-EGTA. J Biol Chem (1983) 0.94
Glucose-induced phospholipid hydrolysis in isolated pancreatic islets: quantitative effects on the phospholipid content of arachidonate and other fatty acids. Biochim Biophys Acta (1986) 0.94
Interleukin-1 enhances pancreatic islet arachidonic acid 12-lipoxygenase product generation by increasing substrate availability through a nitric oxide-dependent mechanism. J Biol Chem (1996) 0.94
Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells. A potential link between insulin resistance and beta-cell dysfunction. J Biol Chem (2001) 0.93
Characterization of the sphingomyelin content of isolated pancreatic islets. Evaluation of the role of sphingomyelin hydrolysis in the action of interleukin-1 to induce islet overproduction of nitric oxide. Biochim Biophys Acta (1996) 0.93
The role of phospholipid-derived mediators including arachidonic acid, its metabolites, and inositoltrisphosphate and of intracellular Ca2+ in glucose-induced insulin secretion by pancreatic islets. Prog Lipid Res (1987) 0.92
Tyrosine kinase involvement in IL-1 beta-induced expression of iNOS by beta-cells purified from islets of Langerhans. Am J Physiol (1994) 0.92
Comparison of effects of phorbol esters and glucose on protein kinase C activation and insulin secretion in pancreatic islets. Biochem J (1989) 0.92
Insulin as a surface marker on isolated cells from rat pancreatic islets. J Cell Biol (1983) 0.92
The effect of glucose on the acute uptake and efflux of calcium-45 in isolated rat islets. Endocrinology (1977) 0.91
Alloxan stimulation and inhibition of insulin release from isolated rat islets of Langerhans. Diabetes (1978) 0.91
Effect of cytochalasin B on hexose transport and glucose metabolism in pancreatic islets. Diabetologia (1974) 0.90
Effects of aspirin on nitric oxide formation and de novo protein synthesis by RINm5F cells and rat islets. Mol Pharmacol (1997) 0.90
Regulation of Ca2+ homeostasis by islet endoplasmic reticulum and its role in insulin secretion. Am J Physiol (1988) 0.90
Ca2+-activated ATPase and ATP-dependent calmodulin-stimulated Ca2+ transport in islet cell plasma membrane. Nature (1980) 0.89
Nitric oxide production by the rat insulinoma cell line, RINm5F, Is specific for IL-1: a spectrophotometric IL-1 bioassay. Anal Biochem (1996) 0.89
Effect of CO2 concentration on intracellular pH and on glycogen synthesis from glycerol and glucose in isolated perfused rat liver. J Biol Chem (1969) 0.89
Hyperglycemic levels of glucose inhibit interleukin 1 release from RAW 264.7 murine macrophages by activation of protein kinase C. J Biol Chem (1998) 0.89
Nitric oxide mediates Bordetella pertussis tracheal cytotoxin damage to the respiratory epithelium. Infect Agents Dis (1993) 0.88
Effect of alloxan on permeability and hexose transport in rat pancreatic islets. Endocrinology (1975) 0.88
Arachidonic acid metabolism in isolated pancreatic islets. III. Effects of exogenous lipoxygenase products and inhibitors on insulin secretion. Biochim Biophys Acta (1985) 0.87
A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism. FASEB J (1993) 0.86
Molecular requirements for recognition at glucoreceptor for insulin release. Mol Pharmacol (1979) 0.86
Monolayer cell culture of adult rat islets of Langerhans. Diabetologia (1974) 0.86
Characterization of the uptake of the methylxanthines theophylline and caffeine in isolated pancreatic islets and their effect on D-glucose transport. Endocrinology (1977) 0.86
Parallel effects of arachidonic acid on insulin secretion, calmodulin-dependent protein kinase activity and protein kinase C activity in pancreatic islets. Cell Calcium (1992) 0.86
Arachidonic acid metabolism and insulin secretion by isolated human pancreatic islets. Diabetes (1988) 0.86
Evidence for a role of microfilaments in insulin release from purified beta-cells. Biochem Biophys Res Commun (1990) 0.85
Modulation of active Ca2+ uptake by the islet-cell endoplasmic reticulum. Biochem J (1983) 0.85
Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes (1998) 0.84
Inhibition of nitric oxide formation does not protect murine cortical cell cultures from N-methyl-D-aspartate neurotoxicity. Brain Res (1993) 0.84
Nitric oxide regulates interleukin 1 bioactivity released from murine macrophages. J Biol Chem (1996) 0.84
Arachidonic acid metabolism in isolated pancreatic islets. IV. Negative ion-mass spectrometric quantitation of monooxygenase product synthesis by liver and islets. Biochim Biophys Acta (1985) 0.84
Specificity of inhibition of calcium- and calmodulin-dependent protein kinase by alloxan. Biochim Biophys Acta (1984) 0.83
Zinc-induced inhibition of insulin secretion from isolated rat islets of Langerhans. Diabetes (1981) 0.82
Interleukin 1-induced prostaglandin E2 accumulation by isolated pancreatic islets. Diabetes (1989) 0.82
Effects of cyproheptadine on insulin secretion by isolated perifused rat islets. Diabetes (1975) 0.81
Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes (1994) 0.81
Activation of calcium and calmodulin dependent protein kinase II during stimulation of insulin secretion. Cell Calcium (1994) 0.81
Distribution of four potential transmitter amino acids in monkey retina. J Neurochem (1977) 0.80
Effect of anomers of D-glucose on alloxan inhibition of insulin release in isolated perifused pancreatic islets. Endocrinology (1976) 0.80
Arachidonic acid metabolism in isolated pancreatic islets. V. The enantiomeric composition of 12-hydroxy-5,8,10,14-eicosatetraenoic acid indicates synthesis by a 12-lipoxygenase rather than a monooxygenase. Biochim Biophys Acta (1989) 0.80
Ninhydrin inhibition of glucose-induced insulin release. Diabetologia (1977) 0.80
Interleukin-1 induces rapid and transient expression of the c-fos proto-oncogene in isolated pancreatic islets and in purified beta-cells. FEBS Lett (1990) 0.79
Glucose-stimulated protein phosphorylation in the pancreatic islet. Biochem J (1984) 0.79